About Michael Silber

This author has not yet filled in any details.
So far Michael Silber has created 2118 blog entries.

Iowa

2023-12-15T10:41:25-05:00December 15, 2023|Iowa|

Louisiana

The Department of Health issued an informational bulletin on tobacco cessation counseling. 

Also in Louisiana, the Department of Health (LDH) updated the available options to providers for pursuing resolution of issues with Medicaid managed care organizations (MCO) and the state’s fee-for-service (FFS) claims processor, Gainwell Technologies. Unless explicitly notated, providers should first seek resolution with the MCO or Gainwell directly, prior to engaging LDH or other third parties. 

Finally in Louisiana, the Board of Pharmacy is soliciting comments and holding a Public Hearing on December 28 on three proposed rule changes: 

  1. Regulatory Project 2023-09 ~ Product Integrity – (temperature control for mail order) 
  2. Regulatory Project 2023-10 ~ Prescription Monitoring Program (PMP)  
  3. Regulatory Project 2023-11 ~ Pharmacists Application 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2023-12-15T10:40:50-05:00December 15, 2023|Louisiana|

Maine

The Board of Pharmacy held its monthly meeting on December 7. The agenda covered the following policies and updates: 

  • Access to HIV Prevention Medications, including PEP and PrEP Protocols 
  • Access to Birth Control by Making Certain Contraception Accessible from a Pharmacist 
  • Authorize Vaccine Administration by Pharmacy Technicians and Reduce Vaccine Administration Training Requirements for Pharmacists 
  • Licensure by Endorsement  
  • Board Rule Chapter Amend Limits on Medication in Vending Machines 
  • Pharmacists Dispense an Emergency Supply of Chronic Maintenance Drugs 
  • Telehealth Rulemaking Status – Update 

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

2023-12-15T10:39:47-05:00December 15, 2023|Maine|

Maryland

Medicaid published an advisory regarding upcoming denials of prescription claims due to the prescribing provider not completing revalidation. The advisory also contains email and phone contacts for patients and provider issues. 

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2023-12-15T10:39:14-05:00December 15, 2023|Maryland|

Massachusetts

MassHealth has issued a new draft of the Pharmacy Manual at 130 CMR 406. The new regulations make the following changes:  

  • Adds compounded drugs, and medically necessary cosmetic drugs for the treatment of alopecia or gender identity that are listed on the MassHealth Drug list, to the list of Covered Drugs and Medical Supplies at 406.412. 
  • Deletes the language in the current regulations at 406.413 that prohibits MassHealth from paying for any drug used for the treatment of obesity. The prohibition has been eliminated and MassHealth will now pay for drugs to treat obesity that are included on the MassHealth Drug List. 
  • Adds the new section 406.446 relative to Pharmacy Drug Review and Counseling that requires pharmacies that are servicing MassHealth patients to offer prospective drug review and counseling that are consistent with the current MA law that requires pharmacists to make an offer to counsel. Only a patient’s refusal of counseling must be documented. 

These changes will become effective on January 1, 2024. 

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

2023-12-15T10:38:38-05:00December 15, 2023|Massachusetts|

Michigan

Gov. Gretchen Whitmer (D) signed HB 4276. The bill requires PBMs to reimburse pharmacies with no more than seven retail outlets at NADAC plus a professional dispensing fee comparable to the state Medicaid Dispensing Fee. It also prohibits the Department of Health and Human Services (department) from entering into a contract with a Medicaid managed care organization if its pharmacy benefit manager (PBM) does not do the following: reimburse for a legally valid claim at a rate not less than the rate in effect at the time the original claim adjudication was submitted at the point of sale; agree to move to a transparent pass-through pricing model, in which the PBM discloses the administrative fee as a percentage of the professional dispensing costs to the department; agree to not create new pharmacy administration fees and to not increase current fees more than the rate of inflation; and, agree to not terminate an existing contract with a pharmacy with no more than seven retail outlets for the sole reason of the additional professional dispensing fee authorized.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2023-12-15T10:38:00-05:00December 15, 2023|Michigan|

Nebraska

The Department of Health and Human Services issued the following provider bulletins: 

Also in Nebraska, the Department of Health and Human Services posted the Excel file of the fee schedule for Injectables October 1, 2023 (Revised). 

Also in Nebraska, the Department of Health and Human Services received approval from CMS for State Plan Amendment 23-0015: Adult Vaccines related to coverage of vaccines and vaccine administration in accordance with current Advisory Committee on Immunization Practices (ACIP) recommendations. 

Finally in Nebraska, the Department of Health and Human Services posted the meeting recording from the December 6 COVID-19 Provider Call. The next meeting will be held on January 3, 2024, at noon (Central). To participate, use either the meeting link or phone number and access code below. 

Join from the meeting link:
https://sonvideo.webex.com/sonvideo/j.php?MTID=mc307e2dda218d1060adfed7f454cfc16
Join by phone:
408-418-9388 (access code: 2480 661 3098 ) 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2023-12-15T10:56:40-05:00December 15, 2023|Nebraska|

New York

NYRx, the State Department of Health Medicaid Pharmacy Benefit Program, released updates to the NYRx Prior Authorization Programs and updated preferred drug list, changes were effective December 14. 

The State Department of Health also released a reminder regarding pharmacy providers and members out-of-pocket costs. This communication was sent to all pharmacies to remind them of their responsibility for continued enrollment, to adhere to the policies and procedures of the Medicaid Program. Specifically, it is inappropriate to allow an eligible member to pay out-of-pocket for services that are covered by NY Medicaid (NYRx) beyond copay. Please be advised that out-of-pocket expenses are only reimbursable by Medicaid for Medicaid covered services when one of these three situations applies:  

  • Reimbursement can be made for both participating and non-participating Medicaid Providers during the three-month retro period up until they submit the application. 
  • Reimbursement can be made for only Medicaid participating Providers from the date the application is submitted up until they receive the Common Benefit Identification Card (CBIC). 
  • Reimbursement can be made for both participating and non-participating Medicaid Providers due to agency error or delay. 

If there is an eligibility issue that is corrected in a timely manner, pharmacists should resubmit the claim when the issue is resolved and reimburse the member directly if the member paid out of pocket. There is support available to pharmacists to assist with claim issues. Questions regarding this communication may be directed to NYRx@health.ny.gov. 

On December 12, A6779, a bill NACDS and the Community Pharmacy Association of New York (CPANY) had been supporting to expand the 2022 law allowing pharmacists to administer long-acting injectables, was sent to the Governor’s desk by the legislature. Gov. Kathy Hochul (D) has until December 22 to act on the legislation. 

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

2023-12-15T10:35:02-05:00December 15, 2023|New York|
Go to Top